Literature DB >> 11029540

Brain-derived neurotrophic factor administration after traumatic brain injury in the rat does not protect against behavioral or histological deficits.

G R Blaha1, R Raghupathi, K E Saatman, T K McIntosh.   

Abstract

Brain-derived neurotrophic factor has been shown to be neuroprotective in models of excitotoxicity, axotomy and cerebral ischemia. The present study evaluated the therapeutic potential of brain-derived neurotrophic factor following traumatic brain injury in the rat. Male Sprague-Dawley rats (N=99) were anesthetized and subjected to lateral fluid percussion brain injury of moderate severity (2.4-2.8 atm) or sham injury. Four hours after injury, the animals were reanesthetized, an indwelling, intraparenchymal cannula was implanted, and infusion of brain-derived neurotrophic factor or phosphate-buffered saline vehicle was initiated from a mini-osmotic pump and continued for two weeks. In Study 1 (N=48), vehicle or 12 microg/day of brain-derived neurotrophic factor was infused into the dorsal hippocampus. In Study 2 (N=51), vehicle or brain-derived neurotrophic factor at a high (12 microg/day) or low dose (1.2 microg/day) was infused into the injured parietal cortex. All animals were evaluated for neurological motor function at two days, one week and two weeks post-injury. Cognitive function (learning and memory) was assessed at two weeks post-injury using a Morris Water Maze. At two weeks post-injury, neuronal loss in the hippocampal CA3 and dentate hilus and in the injured cortex was evaluated. In Study 2, neuronal loss was also quantified in the thalamic medial geniculate nucleus. All of the above outcome measures demonstrated significant deleterious effects of brain injury (P<0.05 compared to sham). However, post-traumatic brain-derived neurotrophic factor infusion did not significantly affect neuromotor function, learning, memory or neuronal loss in the hippocampus, cortex or thalamus when compared to vehicle infusion in brain-injured animals, regardless of the infusion site or infusion dose (P>0.05 for each). In contrast to previous studies of axotomy, ischemia and excitotoxicity, our data indicate that brain-derived neurotrophic factor is not protective against behavioral or histological deficits caused by experimental traumatic brain injury using the delayed, post-traumatic infusion protocol examined in these studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029540     DOI: 10.1016/s0306-4522(00)00214-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  22 in total

1.  Blast-induced tinnitus and hearing loss in rats: behavioral and imaging assays.

Authors:  Johnny C Mao; Edward Pace; Paige Pierozynski; Zhifeng Kou; Yimin Shen; Pamela VandeVord; E Mark Haacke; Xueguo Zhang; Jinsheng Zhang
Journal:  J Neurotrauma       Date:  2011-11-22       Impact factor: 5.269

2.  The Small-Molecule TrkB Agonist 7, 8-Dihydroxyflavone Decreases Hippocampal Newborn Neuron Death After Traumatic Brain Injury.

Authors:  Liang Chen; Xiang Gao; Shu Zhao; Weipeng Hu; Jinhui Chen
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

3.  Brain-Derived Neurotrophic Factor (BDNF) in Traumatic Brain Injury-Related Mortality: Interrelationships Between Genetics and Acute Systemic and Central Nervous System BDNF Profiles.

Authors:  Michelle D Failla; Yvette P Conley; Amy K Wagner
Journal:  Neurorehabil Neural Repair       Date:  2015-05-15       Impact factor: 3.919

Review 4.  Genetic manipulation of cell death and neuroplasticity pathways in traumatic brain injury.

Authors:  Kathleen M Schoch; Sindhu K Madathil; Kathryn E Saatman
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

5.  Voluntary locomotion linked with cerebral activation is mediated by vasopressin V1a receptors in free-moving mice.

Authors:  Shizue Masuki; Eri Sumiyoshi; Taka-aki Koshimizu; Jinze Qian; Keiichi Higuchi; Gozoh Tsujimoto; Hiroshi Nose
Journal:  J Physiol       Date:  2013-05-13       Impact factor: 5.182

Review 6.  Biologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation.

Authors:  Alexandra N Garcia; Mansi A Shah; C Edward Dixon; Amy K Wagner; Anthony E Kline
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

Review 7.  Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Front Neuroendocrinol       Date:  2006-10-20       Impact factor: 8.606

8.  The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.

Authors:  Piotr Hadaczek; Yoji Yamashita; Hanna Mirek; Laszlo Tamas; Martha C Bohn; Charles Noble; John W Park; Krystof Bankiewicz
Journal:  Mol Ther       Date:  2006-05-02       Impact factor: 11.454

9.  Pericontusion axon sprouting is spatially and temporally consistent with a growth-permissive environment after traumatic brain injury.

Authors:  Neil G Harris; Yevgeniya A Mironova; David A Hovda; Richard L Sutton
Journal:  J Neuropathol Exp Neurol       Date:  2010-02       Impact factor: 3.685

10.  VGF (TLQP-62)-induced neurogenesis targets early phase neural progenitor cells in the adult hippocampus and requires glutamate and BDNF signaling.

Authors:  Smita Thakker-Varia; Joseph Behnke; David Doobin; Vidhi Dalal; Keya Thakkar; Farah Khadim; Elizabeth Wilson; Alicia Palmieri; Hanna Antila; Tomi Rantamaki; Janet Alder
Journal:  Stem Cell Res       Date:  2014-03-26       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.